With results continuing to trend toward the high end of expectations and improved visibility into the remainder of the year, the Company is raising the midpoint and narrowing its full-year 2025 financial outlook: including: Revenues of $51 million – $52 million, up from the previous guidance of $50 million – $52 million; Operating income of 6% – 7%, up from the previous guidance of 4% – 5%; and Adjusted EBITDA of 13% – 14%, up from the previous guidance of 12% – 13%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- BWAY Earnings this Week: How Will it Perform?
- BrainsWay Secures NIH Grant for Deep TMS Study on Alcohol Use Disorder
- Brainsway announces NIH awarded a grant totaling about $2.5M over 5 years
- Brainsway’s Strategic Investments and Growth Potential Drive Buy Rating with $17 Price Target
- Brainsway’s Deep TMS Study: A New Hope for Alcohol Use Disorder